EE651 Incremental Cost per Remission in Patients With Rheumatoid Arthritis Who Had Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Colombia
Abstract
Authors
E. Jauregui G.F. Afanador Echeverri